Extendicare Inc. (TSE:EXE – Get Free Report) declared a monthly dividend on Friday, January 31st,TickerTech Dividends reports. Investors of record on Friday, February 14th will be paid a dividend of 0.04 per share on Friday, February 14th. This represents a $0.48 annualized dividend and a dividend yield of 4.63%. The ex-dividend date is Friday, January 31st.
Extendicare Price Performance
Shares of TSE EXE opened at C$10.37 on Wednesday. Extendicare has a 1 year low of C$6.63 and a 1 year high of C$10.89. The company has a debt-to-equity ratio of 305.80, a current ratio of 0.60 and a quick ratio of 0.98. The company’s 50-day moving average is C$10.35 and its 200 day moving average is C$9.16. The stock has a market capitalization of C$865.58 million, a P/E ratio of 15.25 and a beta of 1.26.
Extendicare (TSE:EXE – Get Free Report) last announced its quarterly earnings results on Tuesday, November 12th. The company reported C$0.19 earnings per share (EPS) for the quarter. Extendicare had a net margin of 4.28% and a return on equity of 60.00%. During the same quarter in the previous year, the company earned $0.13 EPS. On average, sell-side analysts expect that Extendicare will post 0.6134729 earnings per share for the current year.
Analyst Upgrades and Downgrades
View Our Latest Stock Analysis on Extendicare
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Stories
- Five stocks we like better than Extendicare
- What is diluted earnings per share (Diluted EPS)?
- 3 Steel Stocks Soaring After Tariff Announcements
- When to Sell a Stock for Profit or Loss
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
- Overbought Stocks Explained: Should You Trade Them?
- Why Salesforce Stock Could Be at Fresh Highs by February
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.